Legis Daily

End Price Gouging for Medications Act

USA116th CongressS-1987| Senate 
| Updated: 6/26/2019
Jeff Merkley

Jeff Merkley

Democratic Senator

Oregon

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 26, 2019
Introduced in Senate
Jun 26, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4569-4570)
Jul 16, 2019

Latest Companion Bill Action

HR 116-3523
Referred to the Subcommittee on Health.
  • June 26, 2019
    Introduced in Senate


  • June 26, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4569-4570)


  • July 16, 2019

    Latest Companion Bill Action

    HR 116-3523
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 116-3523: End Price Gouging for Medications Act
AsiaAustraliaCanadaCivil actions and liabilityEuropeFranceGermanyHealth care costs and insuranceHealth care coverage and accessInflation and pricesItalyJapanMedicaidMedical researchMedicareMilitary medicineNetherlandsNorth AmericaOceaniaPrescription drugsRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care

End Price Gouging for Medications Act

USA116th CongressS-1987| Senate 
| Updated: 6/26/2019
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 26, 2019
Introduced in Senate
Jun 26, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4569-4570)
Jul 16, 2019

Latest Companion Bill Action

HR 116-3523
Referred to the Subcommittee on Health.
  • June 26, 2019
    Introduced in Senate


  • June 26, 2019
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4569-4570)


  • July 16, 2019

    Latest Companion Bill Action

    HR 116-3523
    Referred to the Subcommittee on Health.
Jeff Merkley

Jeff Merkley

Democratic Senator

Oregon

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 116-3523: End Price Gouging for Medications Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaAustraliaCanadaCivil actions and liabilityEuropeFranceGermanyHealth care costs and insuranceHealth care coverage and accessInflation and pricesItalyJapanMedicaidMedical researchMedicareMilitary medicineNetherlandsNorth AmericaOceaniaPrescription drugsRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care